Keros Therapeutics (KROS) Insider Trading & Ownership

$57.97

-1.70 (-2.85%)

(As of 10/9/2024 ET)

Current Insider Ownership Percentage: 22.90%
Number Of Insiders Buying (Last 12 Months): 0
Number Of Insiders Selling (Last 12 Months): 1
Amount Of Insider Selling (Last 12 Months): $11.00 M

Get KROS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Keros Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

KROS Insider Buying and Selling by Quarter

Ad Behind the Markets

⭕ [URGENT] Buy Alert just triggered

My absolute favorite stock just hit a critical "buy now" trigger price.

Click here for the ticker >>>

Keros Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
8/13/2024	Carl L Gordon	Director	Sell	250,000	$44.01	$11,002,500.00

(Data available from 1/1/2013 forward)

KROS Insider Trading Activity - Frequently Asked Questions

: The list of insiders at Keros Therapeutics includes Carl L Gordon, Christopher Rovaldi, Jennifer Lachey, Julius Knowles, and Keith Regnante. Learn more on insiders at KROS.
: 22.90% of Keros Therapeutics stock is owned by insiders. Learn more on KROS's insider holdings.
: The following insiders have sold KROS shares in the last 24 months: Carl L Gordon ($11,002,500.00), and Keith Regnante ($955,800.00).
: Insiders have sold a total of 270,000 Keros Therapeutics shares in the last 24 months for a total of $11,958,300.00 sold.